Stevanato Group (STVN) Scheduled to Post Quarterly Earnings on Thursday

Stevanato Group (NYSE:STVN) is scheduled to be releasing its earnings data before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of €0.12 ($0.13) per share for the quarter. Stevanato Group has set its FY 2024 guidance at 0.670-0.710 EPS and its FY24 guidance at €0.62-0.66 EPS.Persons interested in registering for the company’s earnings conference call can do so using this link.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Thursday, March 7th. The company reported €0.18 ($0.19) EPS for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The company had revenue of €320.60 million for the quarter, compared to analyst estimates of €326.85 million. During the same period last year, the firm earned $0.19 earnings per share. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. On average, analysts expect Stevanato Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Stevanato Group Trading Up 0.7 %

Shares of STVN opened at €28.23 ($30.35) on Thursday. Stevanato Group has a 1 year low of €23.00 ($24.73) and a 1 year high of €36.30 ($39.03). The stock’s 50-day moving average price is €29.87 and its two-hundred day moving average price is €29.28. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50.

Analysts Set New Price Targets

A number of research analysts recently issued reports on STVN shares. Stephens restated an “overweight” rating and set a $38.00 price objective on shares of Stevanato Group in a report on Monday, March 25th. BNP Paribas initiated coverage on Stevanato Group in a report on Monday, April 22nd. They set an “outperform” rating for the company. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $30.00 target price on shares of Stevanato Group in a research report on Monday, April 22nd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of €33.63 ($36.16).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.